Coping with endoplasmic reticulum stress in the cardiovascular system

Annual Review of Physiology

Volumn 75, Issue , 2013, Pages 49-67

  Groenendyk, Jody ^a   Agellon, Luis B ^b   Michalak, Marek ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Cellular reticular network; Energy and nutrient homeostasis; Metabolism; Oxidative stress; Regulon; Unfolded protein response

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ACYL COENZYME A DEHYDROGENASE; ANGIOTENSIN II; CALCINEURIN; CALCIUM ION; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC AMP; CYTOKINE; DICHLOROACETIC ACID; DIMETHYLOXALYLGLYCINE; GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 78; GLYCINE DERIVATIVE; HORMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INITIATION FACTOR 2ALPHA; LIPID; MEMBRANE PROTEIN; MESSENGER RNA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; REACTIVE OXYGEN METABOLITE; STROMAL INTERACTION MOLECULE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR MEF 2C; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NKX2.5; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL DEATH; CELL PROLIFERATION; CYTOKINE PRODUCTION; DRUG MECHANISM; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; ENERGY; FATTY ACID OXIDATION; GENE EXPRESSION; GENE SILENCING; GLYCOLYSIS; GOLGI COMPLEX; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TRANS GOLGI NETWORK; UNFOLDED PROTEIN RESPONSE;

CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MYOCYTES, CARDIAC;

EID: 84873684054     PISSN: 00664278     EISSN: 15451585     Source Type: Book Series    
DOI: 10.1146/annurev-physiol-030212-183707     Document Type: Review

References (139)

1. Benyair R, Ron E, Lederkremer GZ. 2011. Protein quality control, retention, and degradation at the endoplasmic reticulum. Int. Rev. Cell Mol. Biol. 292:197-280
2. 2+ handling in excitable cells in health and disease. Pharmacol. Rev. 63:700-27
3. Braakman I, Bulleid NJ. 2011. Protein folding and modification in the mammalian endoplasmic reticu-lum. Annu. Rev. Biochem. 80:71-99
4. Michalak M, Opas M. 2009. Endoplasmic and sarcoplasmic reticulum in the heart. Trends Cell Biol. 19:253-59
5. Glembotski CC. 2007. Endoplasmic reticulum stress in the heart. Circ. Res. 101:975-84
6. Groenendyk J, Sreenivasaiah PK, Kim DH, Agellon LB, Michalak M. 2010. Biology of endoplasmic reticulum stress in the heart. Circ. Res. 107:1185-97
7. Kimata Y, Kohno K. 2011. Endoplasmic reticulum stress-sensing mechanisms in yeast and mammalian cells. Curr. Opin. Cell Biol. 23:135-42
8. Kraskiewicz H, Fitzgerald U. 2012. InterfERing with endoplasmic reticulum stress. Trends Pharmacol. Sci. 33:53-63
9. Hetz C. 2012. The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat. Rev. Mol. Cell Biol. 13:89-102
10. Tabas I, Ron D. 2011. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13:184-90
11. Back SH, Kaufman RJ. 2012. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81:767-93
12. Tanjore H, Blackwell TS, Lawson WE. 2012. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 302:L721-29
13. Shen Y, Meunier L, Hendershot LM. 2002. Identification and characterization of a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP in vitro and is induced by ER stress. J. Biol. Chem. 277:15947-56
14. Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2:326-32
15. Rutkowski DT, Kaufman RJ. 2004. A trip to the ER: coping with stress. Trends Cell Biol. 14:20-28
16. Yoshida H, Haze K, Yanagi H, Yura T, Mori K. 1998. Identification of the cis-acting endoplasmic retic-ulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J. Biol. Chem. 273:33741-49
17. Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107:881-91
18. Kokame K, Kato H, Miyata T. 2001. Identification of ERSE-II, a new cis-acting element responsible for the ATF6-dependent mammalian unfolded protein response. J. Biol. Chem. 276:9199-205
19. Yamamoto K, Yoshida H, Kokame K, Kaufman RJ, Mori K. 2004. Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. J. Biochem. 136:343-50
20. Wang Y, Shen J, Arenzana N, Tirasophon W, Kaufman RJ, Prywes R. 2000. Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response. J. Biol. Chem. 275:27013-20
21. Rutkowski DT, Arnold SM, Miller CN, Wu J, Li J, et al. 2006. Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins. PLoS Biol. 4:e374
22. Thuerauf DJ, Marcinko M, Gude N, Rubio M, Sussman MA, Glembotski CC. 2006. Activation of the unfolded protein response in infarcted mouse heart and hypoxic cultured cardiac myocytes. Circ. Res. 99:275-82
23. Pan YX, Lin L, Ren AJ, Pan XJ, Chen H, et al. 2004. HSP70 and GRP78 induced by endothelin-1 pretreatment enhance tolerance to hypoxia in cultured neonatal rat cardiomyocytes. J. Cardiovasc. Pharmacol. 44(Suppl. 1):117-20
24. Vitadello M, Penzo D, Petronilli V, Michieli G, Gomirato S, et al. 2003. Overexpression of the stress protein Grp94 reduces cardiomyocyte necrosis due to calcium overload and simulated ischemia. FASEB J. 17:923-25
25. Shintani-Ishida K, Nakajima M, Uemura K, Yoshida K. 2006. Ischemic preconditioning protects car-diomyocytes against ischemic injury by inducing GRP78. Biochem. Biophys. Res. Comm. 345:1600-5
26. Martindale JJ, Fernandez R, Thuerauf D, Whittaker R, Gude N, et al. 2006. Endoplasmic reticulum stress gene induction and protection from ischemia/reperfusion injury in the hearts of transgenic mice with a tamoxifen-regulated form of ATF6. Circ. Res. 98:1186-93
27. Glembotski CC. 2008. The role of the unfolded protein response in the heart. J. Mol. Cell. Cardiol. 44:453-59
28. Doroudgar S, Thuerauf DJ, Marcinko MC, Belmont PJ, Glembotski CC. 2009. Ischemia activates the ATF6 branch of the endoplasmic reticulum stress response. J. Biol. Chem. 284:29735-45
29. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, et al. 2004. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 110:705-12
30. Hamada H, Suzuki M, Yuasa S, Mimura N, Shinozuka N, et al. 2004. Dilated cardiomyopathy caused by aberrant endoplasmic reticulum quality control in mutant KDEL receptor transgenic mice. Mol. Cell. Biol. 24:8007-17
31. George I, Sabbah HN, Xu K, Wang N, Wang J. 2011. β-Adrenergic receptor blockade reduces endo-plasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines. Cardiovasc. Res. 91:447-55
32. Frey N, Olson EN. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:45-79
33. Papp S, Zhang X, Szabo E, Michalak M, Opas M. 2008. Expression of endoplasmic reticulum chaperones in cardiac development. Open Cardiovasc. Med. J. 2:31-35
34. Gargalovic PS, Gharavi NM, Clark MJ, Pagnon J, Yang WP, et al. 2006. The unfolded protein response is an important regulator of inflammatory genes in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 26:2490-96
35. Tabas I. 2010. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ. Res. 107:839-50
36. Teixeira PF, Cerca F, Santos SD, Saraiva MJ. 2006. Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy. J. Biol. Chem. 281:21998-2003
37. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. 2007. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12:331-43
38. Potthoff MJ, Olson EN. 2007. MEF2: a central regulator of diverse developmental programs. Development 134:4131-40
39. Jamali M, Rogerson PJ, Wilton S, Skerjanc IS. 2001. Nkx2-5 activity is essential for cardiomyogenesis. J. Biol. Chem. 276:42252-58
40. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY. 1999. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 13:1037-49
41. Sack MN, Disch DL, Rockman HA, Kelly DP. 1997. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc. Natl. Acad. Sci. USA 94:6438-43
42. Lin CC, Lin JL, Lin CS, Tsai MC, Su MJ, et al. 2004. Activation of the calcineurin-nuclear factor of activated T-cell signal transduction pathway in atrial fibrillation. Chest 126:1926-32
43. van Rooij E, Doevendans PA, de Theije CC, Babiker FA, Molkentin JD, de Windt LJ. 2002. Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy. J. Biol. Chem. 277:48617-26
44. Patient RK, McGhee JD. 2002. The GATA family (vertebrates and invertebrates). Curr. Opin. Genet. Dev. 12:416-22
45. Mao C, Tai WC, Bai Y, Poizat C, Lee AS. 2006. In vivo regulation of Grp78/BiP transcription in the embryonic heart: role of the endoplasmic reticulum stress response element and GATA-4. J. Biol. Chem. 281:8877-87
46. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. 2010. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 90:207-58
47. Tian YC, Fraser D, Attisano L, Phillips AO. 2003. TGF-β1-mediated alterations of renal proximal tubular epithelial cell phenotype. Am. J. Physiol. Ren. Physiol. 285:F130-42
48. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37-51
49. Hogan PG, Lewis RS, Rao A. 2010. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28:491-533
50. 2+ handling in apoptosis. Cell Calcium 32:413-20
51. 2+ influx. Curr. Biol. 15:1235-41
52. 2+ channel function. J. Cell Biol. 169:435-45
53. Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, et al. 2001. Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem. J. 357:673-85
54. 2+ entry through its constitutive and inducible movement in the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 103:16704-9
55. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, et al. 2006. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441:179-85
56. Vig M, Beck A, Billingsley JM, Lis A, Parvez S, et al. 2006. CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr. Biol. 16:2073-79
57. 2+ channel activity. Proc. Natl. Acad. Sci. USA 103:9357-62
58. 2+ entry. J. Cell Sci. 120:1959-65
59. 2+ entry is required for pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 52:136-47
60. Hunton DL, Lucchesi PA, Pang Y, Cheng X, Dell'Italia LJ, Marchase RB. 2002. Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in car-diomyocytes. J. Biol. Chem. 277:14266-73
61. 2+ entry is required for pathological cardiac hypertrophy. J. Mol. Cell. Cardiol. 52:136-47
62. Hulot JS, Fauconnier J, Ramanujam D, Chaanine A, Aubart F, et al. 2011. Critical role for stromal interaction molecule 1 in cardiac hypertrophy. Circulation 124:796-805
63. Voelkers M, Salz M, Herzog N, Frank D, Dolatabadi N, et al. 2010. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J. Mol. Cell. Cardiol. 48:1329-34
64. Szegezdi E, Duffy A, O'Mahoney ME, Logue SE, Mylotte LA, et al. 2006. ER stress contributes to ischemia-induced cardiomyocyte apoptosis. Biochem. Biophys. Res. Commun. 349:1406-11
65. Doroudgar S, Thuerauf DJ, Marcinko MC, Belmont PJ, Glembotski CC. 2009. Ischemia activates the AFT6 branch of the endoplasmic reticulum stress response. J. Biol. Chem. 284:29735-45
66. Shimizu Y, Hendershot LM. 2009. Oxidative folding: cellular strategies for dealing with the resultant equimolar production of reactive oxygen species. Antioxid. Redox Signal. 11:2317-31
67. Shokolenko I, Venediktova N, Bochkareva A, Wilson GL, Alexeyev MF. 2009. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 37:2539-48
68. Unnikrishnan A, Raffoul JJ, Patel HV, Prychitko TM, Anyangwe N, et al. 2009. Oxidative stress alters base excision repair pathway and increases apoptotic response in apurinic/apyrimidinic endonuclease 1/redox factor-1 haploinsufficient mice. Free Radic. Biol. Med. 46:1488-99
69. Natarajan R, Salloum FN, Fisher BJ, Smithson L, Almenara J, Fowler AA 3rd. 2009. Prolyl hydroxylase inhibition attenuates post-ischemic cardiac injury via induction of endoplasmic reticulum stress genes. Vascul. Pharmacol. 51:110-18
70. Schofield CJ, Ratcliffe PJ. 2004. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5:343-54
71. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, et al. 2005. HIF-1 activation attenuates post-ischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Am. J. Physiol. Heart Circ. Physiol. 289:H542-48
72. Bao W, Qin P, Needle S, Erickson-Miller CL, Duffy KJ, et al. 2010. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J. Cardiovasc. Pharmacol. 56:147-55
73. Zhao L, Rosales C, Seburn K, Ron D, Ackerman SL. 2009. Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjogren syndrome. Hum. Mol. Genet. 19:25-35
74. Natarajan R, Salloum FN, Fisher BJ, Ownby ED, Kukreja RC, Fowler AA 3rd. 2007. Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium. Am. J. Physiol. Heart Circ. Physiol. 293:H1571-80
75. Toldo S, Severino A, Abbate A, Baldi A. 2011. The role of PDI as a survival factor in cardiomyocyte ischemia. Methods Enzymol. 489:47-65
76. Oyadomari S, Mori M. 2004. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11:381-89
77. Gross E, Sevier CS, Heldman N, Vitu E, Bentzur M, et al. 2006. Generating disulfides enzymatically: reaction products and electron acceptors of the endoplasmic reticulum thiol oxidase Ero1p. Proc. Natl. Acad. Sci. USA 103:299-304
78. Otsu M, Bertoli G, Fagioli C, Guerini-Rocco E, Nerini-Molteni S, et al. 2006. Dynamic retention of Ero1 ex and Ero1 |3 in the endoplasmic reticulum by interactions with PDI and ERp44. Antioxid. Redox Signal. 8:274-82
79. Li G, Mongillo M, Chin KT, Harding H, Ron D, et al. 2009. Role of ERO1-cx-mediated stimulation of inositol 1, 4, 5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J. Cell Biol. 186:783-92
80. Scheuner D, Song B, McEwen E, Liu C, Laybutt R, et al. 2001. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol. Cell 7:1165-76
81. Zeng L, Lu M, Mori K, Luo S, Lee AS, et al. 2004. ATF6 modulates SREBP2-mediated lipogenesis. EMBOJ. 23:950-58
82. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. 1988. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332:462-64
83. Belmont PJ, Chen WJ, San Pedro MN, Thuerauf DJ, Gellings Lowe N, et al. 2009. Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the ischemic heart. Circ. Res. 106:307-16
84. Liu XH, Zhang ZY, Andersson KB, Husberg C, Enger UH, et al. 2011. Cardiomyocyte-specific disruption of Serca2 in adult mice causes sarco(endo)plasmic reticulum stress and apoptosis. Cell Calcium 49:201-7
85. Xin W, Lu X, Li X, Niu K, Cai J. 2011. Attenuation of endoplasmic reticulum stress-related myocardial apoptosis by SERCA2a gene delivery in ischemic heart disease. Mol. Med. 17:201-10
86. Hasnain SZ, Lourie R, Das I, Chen AC, McGuckin MA. 2012. The interplay between endoplasmic reticulum stress and inflammation. Immunol. Cell Biol. 90:260-70
87. Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC, et al. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-ex and interleukin-6: model of NF-KB-and MAP kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280:21763-72
88. Hansson GK, Libby P. 2006. The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6:508-19
89. Zhang K, Kaufman RJ. 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455-62
90. Williams KJ, Tabas I. 2002. Atherosclerosis and inflammation. Science 297:521-22
91. Tu BP, Weissman JS. 2002. The FAD-and O2-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell 10:983-94
92. Schoonbroodt S, Piette J. 2000. Oxidative stress interference with the nuclear factor-KB activation pathways. Biochem. Pharmacol. 60:1075-83
93. Kumar A, Takada Y, Boriek AM, Aggarwal BB. 2004. Nuclear factor-KB: its role in health and disease. J. Mol. Med. 82:434-48
94. Zhang W, Xing SS, Sun XL, Xing QC. 2009. Overexpression of activated nuclear factor-KB in aorta of patients with coronary atherosclerosis. Clin. Cardiol. 32:E42-47
95. Madonna R, De Caterina R. 2012. Relevance of new drug discovery to reduce NF-KB activation in cardiovascular disease. Vasc. Pharmacol. 57:41-47
96. Xu C, Bailly-Maitre B, Reed JC. 2005. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Investig. 115:2656-64
97. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, et al. 2003. Phosphorylation of the cxsubunit of eukaryotic initiation factor 2 is required for activation of NF-KB in response to diverse cellular stresses. Mol. Cell. Biol. 23:5651-63
98. Deng J, Lu PD, Zhang Y, Scheuner D, Kaufman RJ, et al. 2004. Translational repression mediates activation of nuclear factor KB by phosphorylated translation initiation factor 2. Mol. Cell. Biol. 24:10161-68
99. Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, et al. 2009. Activation of the Akt-NF-KB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J. Immunol. 183:1480-87
100. Hamid T, Guo SZ, Kingery JR, Xiang X, Dawn B, Prabhu SD. 2011. Cardiomyocyte NF-KB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure. Cardiovasc. Res. 89:129-38
101. Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. 2006. Autocrine tumor necrosis factor tx links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1 tx-mediated NF-KB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26:3071-84
102. Wek RC, Jiang HY, Anthony TG. 2006. Coping with stress: eIF2 kinases and translational control. Biochem. Soc. Trans. 34:7-11
103. Nakajima S, Hiramatsu N, Hayakawa K, Saito Y, Kato H, et al. 2011. Selective abrogation of BiP/GRP78 blunts activation of NF-KB through the ATF6 branch of the UPR: involvement of C/EBP |3 and mTOR-dependent dephosphorylation of Akt. Mol. Cell. Biol. 31:1710-18
104. Zhang N, Khachigian LM. 2009. Injury-induced platelet-derived growth factor receptor-tx expression mediated by interleukin-113 (IL-113) release and cooperative transactivation by NF-KB and ATF-4: IL-113 facilitates HDAC-1/2 dissociation from promoter. J. Biol. Chem. 284:27933-43
105. Niu J, Kolattukudy PE. 2009. Role of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implications. Clin. Sci. 117:95-109
106. Kolattukudy PE, Niu J. 2012. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ. Res. 110:174-89
107. Liang J, Saad Y, Lei T, Wang J, Qi D, et al. 2010. MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-KB signaling. J. Exp. Med. 207:2959-73
108. Mizgalska D, Wegrzyn P, Murzyn K, Kasza A, Koj A, et al. 2009. Interleukin-1-inducibleMCPIPprotein has structural and functional properties of RNase and participates in degradation of IL-113 mRNA. FEBS J. 276:7386-99
109. Niiyama H, Kai H, Yamamoto T, Shimada T, Sasaki K, et al. 2004. Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J. Am. Coll. Cardiol. 44:661-66
110. Petrovski G, Das S, Juhasz B, Kertesz A, Tosaki A, Das DK 2011. Cardioprotection by endoplasmic reticulum stress-induced autophagy. Antioxid. Redox Signal. 14:2191-200
111. Wang ZV, Rothermel BA, Hill JA. 2010. Autophagy in hypertensive heart disease. J. Biol. Chem. 285:8509-14
112. Gottlieb RA, Mentzer RM. 2010. Autophagy during cardiac stress: joys and frustrations of autophagy. Annu. Rev. Physiol. 72:45-59
113. De Meyer GR, Martinet W. 2009. Autophagy in the cardiovascular system. Biochim. Biophys. Acta 1793:1485-95
114. Takagi H, Matsui Y, Sadoshima J. 2007. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid. Redox Signal. 9:1373-81
115. Yorimitsu T, Klionsky DJ. 2007. Eating the endoplasmic reticulum: quality control by autophagy. Trends Cell Biol. 17:279-85
116. Gregg D, Rauscher FM, Goldschmidt-Clermont PJ. 2003. Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch. Am. J. Physiol. Cell Physiol. 285:C723-34
117. Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, et al. 2007. Hypertension caused by transgenic overexpression of Rac1. Antioxid. Redox Signal. 9:91-100
118. Brenner B, Koppenhoefer U, Weinstock C, Linderkamp O, Lang F, Gulbins E. 1997. Fas-or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272:22173-81
119. Sutendra G, Dromparis P, Wright P, Bonnet S, Haromy A, et al. 2011. The role of Nogo and the mitochondria-endoplasmic reticulum unit in pulmonary hypertension. Sci. Transl. Med. 3:88ra55
120. Isodono K, Takahashi T, Imoto H, Nakanishi N, Ogata T, et al. 2010. PARM-1 is an endoplasmic reticulum molecule involved in endoplasmic reticulum stress-induced apoptosis in rat cardiac myocytes. PLoS ONE 5:e9746
121. Amin A, Choi SK, Galan M, Kassan M, Partyka M, et al. 2012. Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice. J. Pathol. 227:165-74
122. McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. 2001. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol. Cell. Biol. 21:1249-59
123. Dorn GW 2nd. 2009. Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc. Res. 81:465-73
124. Lee Y, Gustafsson AB. 2009. Role of apoptosis in cardiovascular disease. Apoptosis 14:536-48
125. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 105:13027-32
126. Small EM, Olson EN. 2011. Pervasive roles of microRNAs in cardiovascular biology. Nature 469:336-42
127. Small EM, Frost RJ, Olson EN. 2010. MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022-32
128. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, et al. 2009. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol. Cell 35:856-67
129. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, et al. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-30
130. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-59
131. Behrman S, Acosta-Alvear D, Walter P. 2011. A CHOP-regulated microRNA controls rhodopsin expression. J. Cell Biol. 192:919-27
132. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. 2006. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125:1111-24
133. Chan YC, Banerjee J, Choi SY, Sen CK. 2011. miR-210: the master hypoxamir. Microcirculation 3:215-23
134. Kulshreshtha R, Davuluri RV, Calin GA, Ivan M. 2008. AmicroRNA componentofthe hypoxic response. Cell Death Differ. 15:667-71
135. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, et al. 2008. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283:15878-83
136. Pulkkinen K, Malm T, Turunen M, Koistinaho J, Yla-Herttuala S. 2008. Hypoxia induces microRNA miR-210 in vitro and in vivo: Ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett. 582:2397-401
137. Bartoszewski R, Brewer JW, Rab A, Crossman DK, Bartoszewska S, et al. 2011. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J. Biol. Chem. 286:41862-70
138. Belmont PJ, Chen WJ, Thuerauf DJ, Glembotski CC. 2012. Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response. J. Mol. Cell. Cardiol. 52:1176-82
139. Li G, Luna C, Qiu J, Epstein DL, Gonzalez P. 2011. Role of miR-204 in the regulation of apoptosis, endoplasmic reticulum stress response, and inflammation in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 52:2999-3007